Vaxart, Inc. (VXRT) conducted its Stockholder Fireside Chat conference call on March 13, 2026, at 4:30 PM EDT. The session featured key executives discussing company updates and outlook.
Call Participants
David Carey from Finn Partners opened the call with greetings. Executives included:
- Steven Lo, President, CEO, and Director
- James Cummings, Chief Medical Officer
- Sean Tucker, Senior VP and Chief Scientific Officer
- Jeroen Grasman, CFO, Principal Accounting Officer, and Principal Financial Officer
- Edward Berg, Senior VP and General Counsel
Forward-Looking Statements Disclaimer
Executives highlighted that the discussion includes forward-looking statements on financial results, guidance, business strategies, operations, third-party partnerships, regulatory approvals, cash runway, NASDAQ listing compliance, capital raising, product development, and clinical trials. Actual outcomes may differ materially due to clinical and regulatory uncertainties and other risks detailed in Vaxart’s latest Form 10-K and SEC periodic reports. The company does not plan to update these statements.
